Cargando…

mir-101-3p is a key regulator of tumor metabolism in triple negative breast cancer targeting AMPK

mir-101-3p has been reported to be a tumor suppressor and a promising therapeutic target in cancer. Recently, AMPK dysfunction has been highlighted in cancers, including breast cancer. The aim of this study is to investigate the biological roles of mir-101-3p and AMPK in breast cancer. Our research...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Peng, Ye, Feng, Xie, Xinhua, Li, Xing, Tang, Hailin, Li, Shuaijie, Huang, Xiaojia, Song, Cailu, Wei, Weidong, Xie, Xiaoming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5085220/ https://www.ncbi.nlm.nih.gov/pubmed/27145268 http://dx.doi.org/10.18632/oncotarget.9072

Ejemplares similares

MicroRNA-101 inhibits cell progression and increases paclitaxel sensitivity by suppressing MCL-1 expression in human triple-negative breast cancer
por: Liu, Xiaoping, et al.
Publicado: (2015)

miR-629-3p may serve as a novel biomarker and potential therapeutic target for lung metastases of triple-negative breast cancer
por: Wang, Jin, et al.
Publicado: (2017)

circEPSTI1 as a Prognostic Marker and Mediator of Triple-Negative Breast Cancer Progression
por: Chen, Bo, et al.
Publicado: (2018)

PDL1 And LDHA act as ceRNAs in triple negative breast cancer by regulating miR-34a
por: Huang, Xiaojia, et al.
Publicado: (2017)

The miR-34a-LDHA axis regulates glucose metabolism and tumor growth in breast cancer
por: Xiao, Xiangsheng, et al.
Publicado: (2016)

miR‐200c suppresses stemness and increases cellular sensitivity to trastuzumab in HER2+ breast cancer
por: Tang, Hailin, et al.
Publicado: (2019)

SOX2 Promotes Cell Proliferation and Metastasis in Triple Negative Breast Cancer
por: Liu, Peng, et al.
Publicado: (2018)

Pre-treatment serum alkaline phosphatase and lactate dehydrogenase as prognostic factors in triple negative breast cancer
por: Chen, Bo, et al.
Publicado: (2016)

CircAHNAK1 inhibits proliferation and metastasis of triple-negative breast cancer by modulating miR-421 and RASA1
por: Xiao, Weikai, et al.
Publicado: (2019)

High expression of microRNA-183/182/96 cluster as a prognostic biomarker for breast cancer
por: Song, Cailu, et al.
Publicado: (2016)

Transcriptomic analyses identify key differentially expressed genes and clinical outcomes between triple-negative and non-triple-negative breast cancer
por: Chen, Bo, et al.
Publicado: (2018)

AFAP1-AS1 Promotes Epithelial-Mesenchymal Transition and Tumorigenesis Through Wnt/β-Catenin Signaling Pathway in Triple-Negative Breast Cancer
por: Zhang, Kaiming, et al.
Publicado: (2018)

Corrigendum: AFAP1-AS1 Promotes Epithelial-Mesenchymal Transition and Tumorigenesis Through Wnt/β-Catenin Signaling Pathway in Triple-Negative Breast Cancer
por: Zhang, Kaiming, et al.
Publicado: (2020)

miR-200c inhibits breast cancer proliferation by targeting KRAS
por: Song, Cailu, et al.
Publicado: (2015)

BikDDA, a Mutant of Bik with Longer Half-Life Expression Protein, Can Be a Novel Therapeutic Gene for Triple-Negative Breast Cancer
por: Jiao, Shiping, et al.
Publicado: (2014)

A Novel Platelet-Related Gene Signature for Predicting the Prognosis of Triple-Negative Breast Cancer
por: Xie, Jindong, et al.
Publicado: (2022)

Nomogram to Predict Internal Mammary Lymph Nodes Metastasis in Patients With Breast Cancer
por: Xie, Xinhua, et al.
Publicado: (2019)

Metformin mediates induction of miR‐708 to inhibit self‐renewal and chemoresistance of breast cancer stem cells through targeting CD47
por: Tan, Weige, et al.
Publicado: (2019)

AURKAIP1 actuates tumor progression through stabilizing DDX5 in triple negative breast cancer
por: Tian, Wenwen, et al.
Publicado: (2023)

Pretreatment TG/HDL-C Ratio Is Superior to Triacylglycerol Level as an Independent Prognostic Factor for the Survival of Triple Negative Breast Cancer Patients
por: Dai, Danian, et al.
Publicado: (2016)

AHNAK suppresses tumour proliferation and invasion by targeting multiple pathways in triple-negative breast cancer
por: Chen, Bo, et al.
Publicado: (2017)

circKIF4A acts as a prognostic factor and mediator to regulate the progression of triple-negative breast cancer
por: Tang, Hailin, et al.
Publicado: (2019)

circGFRA1 and GFRA1 act as ceRNAs in triple negative breast cancer by regulating miR-34a
por: He, Rongfang, et al.
Publicado: (2017)

circFBXW7 Inhibits Malignant Progression by Sponging miR-197-3p and Encoding a 185-aa Protein in Triple-Negative Breast Cancer
por: Ye, Feng, et al.
Publicado: (2019)

The Practicability of a Novel Prognostic Index (PI) Model and Comparison with Nottingham Prognostic Index (NPI) in Stage I–III Breast Cancer Patients Undergoing Surgical Treatment
por: Wen, Jiahuai, et al.
Publicado: (2015)

Prognostic Significance of Preoperative Circulating Monocyte Count in Patients With Breast Cancer: Based on a Large Cohort Study
por: Wen, Jiahuai, et al.
Publicado: (2015)

Development and validation of a prognostic nomogram based on the log odds of positive lymph nodes (LODDS) for breast cancer
por: Wen, Jiahuai, et al.
Publicado: (2016)

Is surgical axillary staging necessary in women with T1 breast cancer who are treated with breast-conserving therapy?
por: Wang, Jin, et al.
Publicado: (2019)

Pretreatment Hematocrit Is Superior to Hemoglobin as a Prognostic Factor for Triple Negative Breast Cancer
por: Chen, Bo, et al.
Publicado: (2016)

Landscape of cancer-associated fibroblasts identifies the secreted biglycan as a protumor and immunosuppressive factor in triple-negative breast cancer
por: Zheng, Shaoquan, et al.
Publicado: (2022)

miR-200b as a prognostic factor in breast cancer targets multiple members of RAB family
por: Ye, Feng, et al.
Publicado: (2014)

Development and Verification of a Prognostic Ferroptosis-Related Gene Model in Triple-Negative Breast Cancer
por: Wu, Song, et al.
Publicado: (2022)

Isoliquiritigenin Derivative Regulates miR-374a/BAX Axis to Suppress Triple-Negative Breast Cancer Tumorigenesis and Development
por: Peng, Fu, et al.
Publicado: (2020)

Breast cancer stem cell markers CD44 and ALDH1A1 in serum: distribution and prognostic value in patients with primary breast cancer
por: Kong, Yanan, et al.
Publicado: (2018)

MiR-26a Inhibits Proliferation and Migration of Breast Cancer through Repression of MCL-1
por: Gao, Jie, et al.
Publicado: (2013)

Correction: MiR-26a Inhibits Proliferation and Migration of Breast Cancer through Repression of MCL-1
por: Gao, Jie, et al.
Publicado: (2013)

Key Players in Choline Metabolic Reprograming in Triple-Negative Breast Cancer
por: Iorio, Egidio, et al.
Publicado: (2016)

Establishment of a Cell Necroptosis Index to Predict Prognosis and Drug Sensitivity for Patients With Triple-Negative Breast Cancer
por: Xie, Jindong, et al.
Publicado: (2022)

Role of AMPK and Akt in triple negative breast cancer lung colonization
por: Johnson, Jeremy, et al.
Publicado: (2021)

MiR-101 reverses the hypomethylation of the LMO3 promoter in glioma cells
por: Liu, Xiaoping, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_9jo6b2udade0n2r511t8fm9idi